Medical Treatment for Acute Appendicitis
Long Term Results of Medical Treatment for Acute Appendicitis
1 other identifier
observational
209
1 country
1
Brief Summary
Medical treatment for acute appendicitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 14, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedMarch 12, 2025
March 1, 2025
6.8 years
October 14, 2020
March 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
recuurence
recuurent acute appendicitis
5 years
Interventions
All cases will be treated medically and will be followed for recurrences
Eligibility Criteria
patients with acute appendicitis
You may qualify if:
- clinically and radiologically approved acute appendicitis
- approved and signed the informed consent form
You may not qualify if:
- perforated cases
- cases with peritonitis
- patient wish for surgical treatment
- allergy to drugs used in medical treatment of acute appendicitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (1)
Uşak University
Uşak, 64200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barış Sevinç, M.D.
Uşak University Medical School
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
October 14, 2020
First Posted
October 20, 2020
Study Start
February 1, 2017
Primary Completion
December 1, 2023
Study Completion
January 1, 2024
Last Updated
March 12, 2025
Record last verified: 2025-03